| Pathway ID |
Gene ID |
Gene Symbol |
Gene Name |
| hsa05169 | 10000 | AKT3 | v-akt murine thymoma viral oncogene homolog 3 |
| hsa05169 | 10014 | HDAC5 | histone deacetylase 5 |
| hsa05169 | 1017 | CDK2 | Cyclin-dependent kinase 2 |
| hsa05169 | 1026 | CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| hsa05169 | 1027 | CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
| hsa05169 | 1386 | ATF2 | activating transcription factor 2 |
| hsa05169 | 1432 | MAPK14 | mitogen-activated protein kinase 14 |
| hsa05169 | 2033 | EP300 | E1A binding protein p300 |
| hsa05169 | 207 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
| hsa05169 | 208 | AKT2 | V-akt murine thymoma viral oncogene homolog 2 |
| hsa05169 | 2268 | FGR | FGR proto-oncogene, Src family tyrosine kinase |
| hsa05169 | 23533 | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 |
| hsa05169 | 27044 | SND1 | staphylococcal nuclease and tudor domain containing 1 |
| hsa05169 | 29110 | TBK1 | TANK-binding kinase 1 |
| hsa05169 | 2932 | GSK3B | glycogen synthase kinase 3 beta |
| hsa05169 | 2960 | GTF2E1 | General transcription factor IIE, polypeptide 1, alpha 56kDa |
| hsa05169 | 3065 | HDAC1 | Histone deacetylase 1 |
| hsa05169 | 3066 | HDAC2 | histone deacetylase 2 |
| hsa05169 | 3105 | HLA-A | major histocompatibility complex, class I, A |
| hsa05169 | 3107 | HLA-C | major histocompatibility complex, class I, C |
| hsa05169 | 3119 | HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
| hsa05169 | 3133 | HLA-E | major histocompatibility complex, class I, E |
| hsa05169 | 3135 | HLA-G | HLA-G histocompatibility antigen, class I, G |
| hsa05169 | 3303 | HSPA1A | Heat shock 70kDa protein 1A |
| hsa05169 | 3304 | HSPA1B | Heat shock 70kDa protein 1B |
| hsa05169 | 3312 | HSPA8 | Heat shock 70kDa protein 8 |
| hsa05169 | 3315 | HSPB1 | heat shock 27kDa protein 1 |
| hsa05169 | 3383 | ICAM1 | Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor |
| hsa05169 | 3458 | IFNG | Interferon, gamma |
| hsa05169 | 3551 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
| hsa05169 | 3586 | IL10 | Interleukin 10 |
| hsa05169 | 3661 | IRF3 | interferon regulatory factor 3 |
| hsa05169 | 3716 | JAK1 | Janus kinase 1 |
| hsa05169 | 3718 | JAK3 | Janus kinase 3 |
| hsa05169 | 3725 | JUN | Jun oncogene |
| hsa05169 | 4067 | LYN | V-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| hsa05169 | 4193 | MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase |
| hsa05169 | 440275 | EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 |
| hsa05169 | 4609 | MYC | v-myc avian myelocytomatosis viral oncogene homolog |
| hsa05169 | 4734 | NEDD4 | Neural precursor cell expressed, developmentally down-regulated 4 |
| hsa05169 | 4790 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
| hsa05169 | 4791 | NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
| hsa05169 | 4792 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| hsa05169 | 5290 | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
| hsa05169 | 5291 | PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
| hsa05169 | 5293 | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
| hsa05169 | 5294 | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
| hsa05169 | 5295 | PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) |
| hsa05169 | 5296 | PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
| hsa05169 | 5435 | POLR2F | polymerase (RNA) II (DNA directed) polypeptide F |
| hsa05169 | 5441 | POLR2L | polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa |
| hsa05169 | 5599 | MAPK8 | mitogen-activated protein kinase 8 |
| hsa05169 | 5600 | MAPK11 | mitogen-activated protein kinase 11 |
| hsa05169 | 5601 | MAPK9 | mitogen-activated protein kinase 9 |
| hsa05169 | 5606 | MAP2K3 | mitogen-activated protein kinase kinase 3 |
| hsa05169 | 5608 | MAP2K6 | mitogen-activated protein kinase kinase 6 |
| hsa05169 | 5609 | MAP2K7 | mitogen-activated protein kinase kinase 7 |
| hsa05169 | 5901 | RAN | RAN, member RAS oncogene family |
| hsa05169 | 596 | BCL2 | B-cell CLL/lymphoma 2 |
| hsa05169 | 5970 | RELA | v-rel avian reticuloendotheliosis viral oncogene homolog A |
| hsa05169 | 5971 | RELB | v-rel avian reticuloendotheliosis viral oncogene homolog B |
| hsa05169 | 6416 | MAP2K4 | mitogen-activated protein kinase kinase 4 |
| hsa05169 | 6502 | SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
| hsa05169 | 6774 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
| hsa05169 | 6850 | SYK | spleen tyrosine kinase |
| hsa05169 | 7128 | TNFAIP3 | Tumor necrosis factor, alpha-induced protein 3 |
| hsa05169 | 7157 | TP53 | tumor protein p53 |
| hsa05169 | 7185 | TRAF1 | TNF receptor-associated factor 1 |
| hsa05169 | 7189 | TRAF6 | TNF receptor-associated factor 6, E3 ubiquitin protein ligase |
| hsa05169 | 7297 | TYK2 | tyrosine kinase 2 |
| hsa05169 | 7431 | VIM | Vimentin |
| hsa05169 | 7531 | YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
| hsa05169 | 7874 | USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) |
| hsa05169 | 8021 | NUP214 | Nucleoporin 214kDa |
| hsa05169 | 8503 | PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
| hsa05169 | 8737 | RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
| hsa05169 | 8900 | CCNA1 | cyclin A1 |
| hsa05169 | 9020 | MAP3K14 | Mitogen-activated protein kinase kinase kinase 14 |
| hsa05169 | 9519 | TBPL1 | TBP-like 1 |
| hsa05169 | 958 | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
| hsa05169 | 960 | CD44 | CD44 molecule (Indian blood group) |
| hsa05169 | 965 | CD58 | CD58 molecule |
| hsa05169 | 983 | CDK1 | cyclin-dependent kinase 1 |